聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 48 分钟 11 秒 前

Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer Transaction

周三, 04/06/2016 - 15:06
Pfizer-Allergan Merger Agreement Terminated Allergan's Leading Commercial Franchises, 70+ Mid-to-Late Stage Pipeline Projects to Fuel Continued Strong Top-Line Growth in 2016 and Beyond Powerful Financial Profile and Balance Sheet Provides Optionalit...
Biopharmaceuticals, Mergers & Acquisitions
Allergan, Pfizer

Pfizer Announces Termination of Proposed Combination with Allergan

周三, 04/06/2016 - 15:04
NEW YORK, NY--(Healthcare Sales & Marketing Network)--Pfizer Inc. (PFE) today announced that the merger agreement between Pfizer and Allergan plc (AGN) has been terminated by mutual agreement of the companies. The decision was driven by the actions announc...
Biopharmaceuticals, Mergers & Acquisitions
Pfizer, Allergan

Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients

周三, 04/06/2016 - 15:02
Novel liquid biopsy RAS testing now available to clinical practices for metastatic colorectal cancer (mCRC) patients The test will help guide physicians to select the most effective treatment for mCRC patients in a timely manner DARMSTADT, Germany, ...
Diagnostics, Oncology, Regulatory
Merck, Sysmex Inostics, OncoBEAM, colorectal cancer

Sorrento Appoints Kevin M. Herde As Chief Financial Officer

周三, 04/06/2016 - 14:57
SAN DIEGO, April 5, 2016 -- (Healthcare Sales & Marketing Network) -- Sorrento Therapeutics, Inc. (SRNE), an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases, today annou...
Biopharmaceuticals, Personnel
Sorrento Therapeutics, resiniferatoxin

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong